Report Highlights
The global market for cardiovascular devices is expected to grow from $72.4 billion in 2025 and is projected to reach $101.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.0% during the forecast period of 2025 to 2030.
Report Includes
- 69 data tables and 73 additional tables
- An overview and analysis of the global cardiovascular devices market
- Analyses of global market trends, with revenue data for 2022-2025, and projections of CAGRs through 2030
- Estimates of the current market size and future revenue growth prospects, accompanied by a market share analysis by product, end user, and region
- Facts and figures pertaining to market dynamics, including key drivers, restraints, opportunities, challenges, and the impact of macroeconomic factors
- Review of regulatory frameworks across major regions, along with an assessment of approval pathways and compliance requirements
- Insights into emerging technologies and developments, including innovations in minimally invasive devices, remote patient monitoring, and implantable cardiovascular technologies
- Patent analysis highlighting key granted and published patents related to cardiovascular medical devices
- Analysis of the competitive landscape, including company market share rankings, strategic initiatives, partnerships, and recent developments
- Overview of sustainability trends and ESG developments in the global cardiovascular devices market
- Profiles of the leading global companies, including Medtronic, Abbott, Boston Scientific Corp., Edwards Lifesciences Corp., and Johnson & Johnson
Report Scope
The report provides an overview of the global cardiovascular devices market and analyzes market trends. It includes global revenue ($ million) using 2024 as the base year, estimated data for 2025, and projected data for 2026 through 2030.
The market is segmented by product and end user. Based on product, the cardiovascular devices market is segmented into interventional cardiology, cardiac rhythm management, diagnostics and monitoring, cardiac assist devices, electrophysiology, and other vascular surgery devices. Based on end users, the market is segmented into hospitals and clinics, ambulatory surgical centers, diagnostic laboratories, and other end users. Geographical regions covered in this study are North America (the U.S., Canada, and Mexico), Europe (Germany, the U.K., Italy, France, Spain, and the rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia-Pacific), the Middle East and Africa (MEA), and South America, focusing on all the major countries in these regions.
The report focuses on the key driving trends and challenges shaping the market and vendor landscape. It analyzes and discusses emerging technologies related to the market.
The report concludes by analyzing the competitive landscape and providing the leading global cardiovascular devices companies. It also includes a dedicated section of company profiles that covers overviews, key financials, product portfolios, and recent developments for major companies.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2024 | ||||||||||||||||
| Forecast period considered | 2025-2030 | ||||||||||||||||
| Base year market size | $67.9 Billion | ||||||||||||||||
| Market size forecast | $101.6 Billion | ||||||||||||||||
| Growth rate | CAGR of 7% for the forecast period of 2025-2030 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | Product, End User, and Region | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, South America and Middle East and Africa | ||||||||||||||||
| Countries covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, and Australia | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
||||||||||||||||
Frequently Asked Questions (FAQs)
- Rising prevalence of cardiovascular disorders and other lifestyle-related disorders.
- Growing demand for minimally invasive procedures in cardiovascular treatment.
- Increasing adoption of remote patient monitoring for cardiac disease management.
- Complex product development.
- Complications associated with implantable devices.
- Growing demand for preventive and early-diagnosis solutions.
- Increasing focus on value-based healthcare.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Congenital Heart Defect Devices: Focus on the U.S. Market
The goals of this study were to understand the current market scenario for congenital heart defect devices in the U.S. and to determine the market's growth potential over the period from 2018 through the end of 2035. The study explores market dynamics such as drivers, restraints, opportunities and trends that impact the growth of the market. The main objective of this report is to present a comprehensive analysis of the current market for congenital heart defect devices in the U.S.
Cardiac Equipment: Technologies and Global Markets
The global market for cardiac medical devices was valued at nearly $49.4 billion in 2013 and $52 billion in 2014. This market is projected to reach nearly $67.5 billion by 2019, with a compound annual growth rate (CAGR) of 5.3% from 2014 to 2019.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
State of the Life Sciences Industry - 2026 Second Quarter Review
Discover BCC Research’s Q2 2026 life sciences industry review, highlighting market trends, innovation, sector performance, and growth opportunities.
Cardiovascular Devices: Global Markets to 2030
The global market for cardiovascular devices is expected to grow from $72.4 billion in 2025 and is projected to reach $101.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.0% during the forecast period of 2025 to 2030.
Global Healthcare Fraud Detection Market
This report provides a brief general outlook of the global healthcare fraud detection market. It includes global revenue ($ million) for base year data of 2024, estimated data of 2025, and forecasts through 2030. The report focuses on the significant driving trends and challenges that affect the global market and its vendor landscape.
Global Orthopedic Surgical Robots Market
The global market for orthopedic surgical robots was valued at $2.7 billion in 2025 and is expected to reach $4.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.4% from 2025 to 2030.
Chronic Kidney Disease: Global Markets and Technologies
The global market for chronic kidney disease was valued at $52.9 billion in 2025 and is estimated to reach $82.6 billion by 2030, at a compound annual growth rate (CAGR) of 9.3% from 2025 through 2030.
Top Trending Reports
2025 Medical Devices Research Review
Get a concise view of the medical devices sector with BCC Research’s 2025 review covering market dynamics, emerging technologies and industry developments.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies (SUTs) for biopharmaceuticals was valued at $8.3 billion in 2025 and, is estimated to reach $9.2 billion by 2026 and $16.3 billion by 2031, at a compound annual growth rate (CAGR) of 12.2% from 2026 through 2031.
Biologic Therapies for Wound Care: Technologies and Global Markets
The global market for wound care biologics is expected to grow from $7 billion in 2025 and is projected to reach $10.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.1% during the forecast period of 2025 to 2030.
Power Infrastructure for Data Centers: Global Markets
This report provides a comprehensive analysis of global power infrastructure for data centers market, segmented by power infrastructure component, data center type, and end-use. It includes global revenue for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The report focuses on trends, challenges, and the competitive landscape, including market share of leading companies and company profiles with financials, product portfolios, and recent developments.
Bioinformatics: Technologies and Global Markets
The global bioinformatics market was valued at $23.5 billion in 2025 and is estimated to reach $43.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 to 2030.
Report Highlights
The global market for cardiovascular devices reached nearly $42.4 billion in 2017 and should reach $59.1 billion by 2022, at a compound annual growth rate (CAGR) of 6.9% for the period of 2017-2022.
Report Includes
- An overview of the global markets for cardiovascular devices
- Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Discussion of key cardiovascular procedures, disease areas, and end users
- Information on cardiovascular devices, including diagnostics and monitoring, interventional cardiology, cardiac rhythm management, cardiac assist, and other vascular surgery devices
- Analysis of market drivers, restraints, and opportunities
- Coverage of key mergers and acquisitions, new product launches, agreements, collaborations, and partnerships
- Patent analysis of various devices by year and by assignee
- Profiles of major players in the industry including Abbott Vascular, Abiomed Inc., B. Braun Melsungen AG, Cardinal Health Inc., GE Healthcare, Johnson & Johnson, Medtronic PLC and Philips Healthcare
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More